Capsule Filler & Capsule Filling Resources

CAPSULE FILLER & CAPSULE FILLING: PRODUCTS, SERVICES, WHITE PAPERS, AND ARTICLES

• How The New $1.2T Infrastructure Bill Will Help Colorado Brace For The Next Disaster

  Keith Porter is an adjunct professor in the Department of Civil, Environmental, and Architectural Engineering at CU Boulder. He led a 2019 report in which he and his colleagues argued spending money now could save the nation trillions of dollars in coming decades. In this Q&A, Porter discusses the new infrastructure bill and why living with aging roads and bridges is like living with credit card debt.

• Meeting Customers Where They Are With Mobile Technology

  Field Technologies Online talks with Panasonic’s Chad Hall about how rugged mobile solutions can close the gap in customer experience, increase workforce optimization, and level-up productivity for utility workers.

• How Fulcrum Therapeutics Protects Its Data

  Maintaining GxP compliance, creating a secure environment for collaboration, and ensuring there is a single source of truth are becoming more and more of a hassle. Read how Fulcrum has turned to technology to help automate many of these processes in order to streamline collaboration with third-parties and the organization of data into a single repository.

• Do You Anticipate Attending The Annual J.P. Morgan Healthcare Conference In Person In January 2022?

  See the answer from Pamela Reilly Contag, Ph.D., the CEO and president of BioEclipse Therapeutics.

• What Is Your Opinion On The Practical Applications Of CRISPR Cas9 And Will We See A Commercial Application Of This Technology In The Next Decade?

  See the answer from Sandy Macrae, M.B., Ch.B., Ph.D., CEO of Sangamo Therapeutics.

• Advanced Tech Can Thwart Site Staffing Problems

  In clinical research, staffing shortages can delay trials and prevent new therapies from getting to patients in need. Read why Melissa Easy, VP, Clinical Technologies at IQVIA, believes advanced tech may bridge this gap as she reviews tools that are proving useful to study teams.

• What Global Macro Trends Are You Paying Closest Attention To And Why?

  See the answer from Dr. Carol Nacy, CEO of Sequella, Inc., a private company that develops new antiinfective drugs

• Water And Hospitality Come Together To Tackle FOG

  Water companies are prioritizing engagement with the hospitality sector in their drive to keep sewers free of fats, oils and grease (FOG). Network protection managers at Southern Water and United Utilities, Stephen Williams and Andrew Peet, tell Laura Su, managing director of the European FOG Summit, why cross-sector partnerships must be forged.

• Hitting The Target With Good Study Design

  Get insight from a discussion about the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and the tips for designing it on your own.

• Given The Risk Profile Of An Emerging Company, What Is The Appropriate Compensation Mix Between Salary, Short-, And Long-Term (Stock) To Attract Talent?

  See the answer from Kenneth Moch, who has been president and CEO of five life science companies, most recently with Cognition Therapeutics.

• Specialized Scientific Support Streamlines Clinical Trials

  Achieving appropriate scientific oversight and thorough, efficient sample management throughout studies are challenges that many pharma and biotech companies encounter. In this Q&A, explore a highly specialized outsourcing model that address these challenges.

• A CRO's Way Forward In The Midst Of A Pandemic: QPS Operations And COVID-19

  In this Q&A, QPS Holdings LLC Chairman President, and CEO, Ben Chien, Ph.D., reflects on the progress of the company’s growth from a small, three-person start-up to a mid-sized CRO, the impact COVID-19 has had on drug development and clinical trials, and the way forward for CROs in the midst of a pandemic.

• The Role Of QPs In Meeting The Challenges Of Increasingly Complex Supply Chains

  Drug development can take place at a rapid pace, so quality assurance and QPs are challenged to keep up with the evolving scientific and regulatory requirements. Explore the benefits of partnering with a contract packaging organization that can offer integrated QP services.

• LNPs vs. Conventional Liposomes: Core Structural And Manufacturing Differences

  Key differences exist between liposomes and lipid nanoparticles (LNPs), not only in their target applications, but with their actual morphology, composition, and manufacturing process.

• Quantifying Sleep In The Real World

  ActiGraph Chief Scientific Officer Christine Guo speaks to Dr. Jennifer Walsh about her experiences and the surprising insights her team uncovered as they conducted the first RCT to deploy self-reports, actigraphy, and PSG to rigorously examine treatment effect of a medical cannabis product for insomnia.

• Clinical Trials & Europe: Sponsor And CRO Feedback On Automating Participant Reimbursement

  Find out why sponsors and CROs in Europe are increasingly turning to technology to automate their patient engagement processes, garnering positive feedback from sites.

• Measuring Aspects Of Health In Heart Failure Research

  Dr. Bill Byrom sat with Cardiology Professor Marianna Fontana to discuss opportunities for measuring aspects of health meaningful for increasing the usefulness of COA measures in heart failure trials.

• A Q&A With Joshua Cantone, CEO Of Optimatics

  Optimatics is changing the trajectory of public utility economics, powering outcome-driven analytics strategies that achieve new levels of operational and community impact. With Optimatics, infrastructure leaders leverage an intelligent platform combined with their engineering judgment to explore the full range of options and tackle complex decision-making with confidence. Optimatics drives infrastructure strategies for more than 75 million citizens across 300 utilities and 3 continents. Engineers at their core, the team’s real-world expertise, heritage of innovation and proven IP has made them a trusted strategic partner around the globe.

• The Key Enablers Of Late-Phase Biologics Development And Launch

  Dr. Claudia Müller answers questions from a webinar about the complex path to a successful product launch, which requires a holistic development strategy driven by a well-defined target product profile.

• FAQs: What Is A Digital Water Platform, And How Will It Shape The Future?

  Here are a few most frequently asked questions about digital water platforms — what they are, how they benefit utilities, and how they will shape the future of the water industry.

• What Were Your Impressions Of Presenting At A Virtual JPM, And How Do You Think This Year's Show Will Impact Future Jpms?

  See the answer from Ron Cohen, M.D.; president, CEO, and founder of Acorda Therapeutics.

• What Was The Biggest Insight You Gained From Working As A Biopharma Manufacturing Exec During The Pandemic?

  See the answer from Jacks Lee, SVP global manufacturing and supply at Merck. He has 25+ years of experience in vaccines, biopharmaceuticals, and small molecule pharmaceuticals.

• Understanding The White House's Get The Lead Out Partnership, With One Of Its Participants

  In late January, the White House welcomed over 100 organizations for the launch of the Biden-Harris Get the Lead Out Partnership, which seeks replacement of 100% of the nation’s lead service lines (LSLs) in 10 years. The organizations that were on hand come from various sectors, but all have a vested interest in ‘getting the lead out’ and improving water quality for consumers, and all have partnered with the Administration to achieve the lofty goal of complete LSL removal.

• Frequently Asked Questions: 2023 EMA And FDA Guidance

  Delve into critical questions posed by clinical trial teams regarding their awareness of new eCOA-related regulatory guidance published this year and what teams should know to ensure compliance is met.

• New Technologies To Improve Solubility Of Brick Dust Compounds

  David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

• Feds Announce Historic Water Cuts: What Does This Mean?

  John Fleck, director of The University of New Mexico’s Water Resource Program, answers questions on the federal announcement of historic water cuts for portions of the western United States, who it will impact most, how everyday people can help, and what future steps might look like.

• How To Use Digital Technology To Increase Clinical Trial Diversity

  In this Q&A, Medable and Scott Treiber, Vice President, Strategic Development at Synteract delve into issues with clinical trial diversity, the FDA’s role and new guidance, and new technologies that can help.

• Paging Dr. Weinberger: Advice On How To Treat America's Cybersecurity Threat

  Alan Weinberger is an educator, entrepreneur, lawyer, and businessman, as well as the founder, CEO, and chairman of The ASCII Group. Weinberger recently added “author” to his list of accomplishments with the publication of The Doctor's In: Treating America's Greatest Cyber Security Threat, a look at the new freedoms of this era that have caused disruptions, mainly as the internet ‘flattens’ our world and accelerates outcomes that can be felt around the globe. Weinberger recently took the time to explain why he wrote this book, as well as offer up his thoughts on the channel and more.

• What Challenges Does Remote Work Present A Biopharma CEO?

  See the answer from Leslie Williams, a 25-year biopharma industry veteran and experienced biotech CEO and board of directors’ member.

• From Reactive To Proactive

  The Water Online editorial staff sat down for a brief chat with Lou Arone, Schneider Electric’s US Manager of the System & Architectures Team, Industrial Automation Business, as well as Vincent Puisor, Schneider’s Business Development Manager for Water & Wastewater in the Americas Region, to discuss water industry challenges and the solutions that Schneider has to offer. Below is our conversation, lightly edited for clarity and length.

• The Next Frontier: Industrializing Cell Therapy Manufacturing

  Learn how leveraging platform processes can enable flexible service at each level – pre-clinical through commercial – and reduce development timelines and costs on the path to market.

• Revisiting Perspectives On 'Water For Development': Keys To Project Development And Financing

  A Q&A with Xavier Leflaive, Water Team Lead, Organisation for Economic Co-operation and Development (OECD) Environment Directorate

• The Potential Of Pulsed Light Decontamination In Sterile Fill-Finish

  Pulsed light technology is a new sterilization solution that further reduces the risk of contamination. We discuss how the technology works, its advantages over other sanitation tools, and its proven effectiveness against harmful bacteria and viruses.

• Driving Quality And Speed In Data Acquisition

  Uncover how a clinical database programming team was able to ensure data quality, accelerating cycle times, and the overall success of a clinical trial.

• Biotech And CAR-T Research In China

  Novotech hosted a webinar highlighting China’s rapidly expanding biotech research. After the event, experts answered questions on biotech and CAR T cell therapy research in China.

• Globalization: The DNA Of DIA

  Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2024.

• Faster Determination Of Dynamic Binding Capacity

  Streamline the downstream process using variable pathlength technology to determine the DBC of affinity chromatography resins to produce reliable data more effectively and efficiently.

• Putting PFAS In The Past Michelle Bellanca, CEO of cleantech company Claros Technologies, shares her thoughts on how to fix the nation's PFAS problem.
• As A Mentor In Biopharma, What Is The One Piece Of Advice You Consistently Offer To Those You Mentor?

  See the answer from Rich Daly, COO of Beyond Spring.

• 7 Industry Leaders Weigh In On Patient Engagement & Recruitment

  Gain insights from leaders representing different facets of the clinical trial ecosystem regarding study activities and industry learnings that encourage successful trial outcomes.